September 11, 2024 Top Stocks For Smart Investment Choices
September 8, 2024 S&P 500 In Freefall: Is This The End Of The Bull Market?
September 6, 2024 Jobs Report Spotlight As Fed Weighs Rate Cut Decision
August 26, 2024 NVDA Earnings Report Insights
Nvidia: Make Hay While The Sun Shines
Apple: Not Ready To Glow Up
Nvidia: The King Of Semiconductor Stocks Is Back – Still Cheap Here
Tesla Robotaxi: Fool Me Ten Times, Shame On Me
Amazon: Oracle Partnership Highlights Margin Expansion Potential
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
CRISPR Therapeutics (CRSP) dividend
When will CRISPR Therapeutics pay the next dividends?
The date of payment of the next dividends from the CRISPR Therapeutics is scheduled for N/A.
If you see an old date, it means that the company has not yet approved a new dividend payout date. As soon as they do, we will update the information immediately. Bookmark our site to stay informed.
CRISPR Therapeutics dividend per share:
Dividends are paid at $ None per share.
CRISPR Therapeutics dividend history:
Previous date of dividend payment: N/A.
Splitting upCRISPR Therapeutics shares:
No information concerning CRISPR Therapeutics splitting shares.
Last Split Factor: N/A
CRISPR Therapeutics stock forecast.
What will happen to CRISPR Therapeutics stock? CRISPR Therapeutics shares will rise or fall. Visit the prediction section of our website to get an answer to this question.
Sell or Buy CRISPR Therapeutics (CRSP) stocks? Analytic Experts Forecasting...
CRISPR Therapeutics stock chart in real time
A real-time chart of the CRISPR Therapeutics stock price is shown below. By default, the chart is set to the daily timeframe, but you can change it to the one that interests you. You can also use indicators on the chart.
CRISPR Therapeutics information and performance
CRISPR Therapeutics Address
BAARERSTRASSE 14, ZUG, CH
Market Capitalization: 4 168 132 000 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: -335 172 992 $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: None
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: -0.214
Price/earnings to growth
DPS: None
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
DY: None
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS: -3.2
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: -0.993
Trailing PE: -
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: 23.36
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: 19.49
Enterprise Value (EV) /Revenue
EV To EBITDA: 14.16
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 85168000
Number of issued ordinary shares
Shares Float:
Number of freely tradable shares
Shares Short Prior Month:
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio:
Percent Insiders:
Percent Institutions: